483
Laurus Labs Limited (Unit-5)FDA 483 - Laurus Labs Limited (Unit-5) - October 28, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
During an inspection of Laurus Labs Limited, Unit-5 in Anakapalli, India, the FDA observed a significant deficiency related to facility conditions. Specifically, the firm failed to provide adequate lighting in a critical solvent dispensing area used for intermediate and API manufacturing. This issue could impact the safety and quality of pharmaceutical production.
Open in Dashboard
ID · e077f27e-e6e9-430b-93a3-b8b529bf8eb7